These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma. Jian CX, Yang MZ, Li P, Xiong J, Zhang ZJ, Li CJ, Chen A, Hu CM, Zhou JX, Li SH. Cancer Invest; 2012 Dec; 30(10):748-56. PubMed ID: 23088770 [Abstract] [Full Text] [Related]
4. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H. Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138 [Abstract] [Full Text] [Related]
5. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ. Breast Cancer Res; 2011 Feb; 13(6):R111. PubMed ID: 22053985 [Abstract] [Full Text] [Related]
6. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells. Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME. Mol Pharm; 2015 Jul 06; 12(7):2406-17. PubMed ID: 26020100 [Abstract] [Full Text] [Related]
9. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer. Song W, Li W, Li L, Zhang S, Yan X, Wen X, Zhang X, Tian H, Li A, Hu JF, Cui J. Oncotarget; 2015 Sep 15; 6(27):23764-75. PubMed ID: 26156017 [Abstract] [Full Text] [Related]
10. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A. Breast Cancer Res Treat; 2011 Apr 15; 126(2):373-84. PubMed ID: 20464481 [Abstract] [Full Text] [Related]
12. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC. Nature; 2000 Aug 17; 406(6797):742-7. PubMed ID: 10963601 [Abstract] [Full Text] [Related]
13. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Am J Pathol; 2002 Feb 17; 160(2):579-84. PubMed ID: 11839578 [Abstract] [Full Text] [Related]
14. Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase. Chen P, Shen WZ, Karnik P. Int J Cancer; 2004 Oct 10; 111(6):881-91. PubMed ID: 15300800 [Abstract] [Full Text] [Related]
15. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H, Mansel RE, Jiang WG. Int J Oncol; 2005 May 10; 26(5):1429-34. PubMed ID: 15809737 [Abstract] [Full Text] [Related]
17. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V. Biochem Pharmacol; 2007 Feb 15; 73(4):491-503. PubMed ID: 17126818 [Abstract] [Full Text] [Related]